전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
cpk increased
sage: suurenenud cpk
마지막 업데이트: 2012-04-11
사용 빈도: 2
품질:
elevations of cpk
kreatiinfosfokinaasi taseme tõus
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
increased blood cpk
vere kpk aktiivsuse tõus
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
increased cpk, myalgia
kreatiinfosfokinaasi taseme suurenemine, müalgia
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
common: cpk increased
sage: cpk tõus
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
cpk elevations2, alt/ast elevations2
kreatiinfosfokinaasi (kfk) aktiivsuse suurenemine2, alat/asat aktiivsuse suurenemine2
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
creatine phosphokinase (cpk) elevations
kreatiinfosfokinaasi (kfk) aktiivsuse suurenemine
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
blood creatine phosphokinase (cpk) increased
kreatiini fosfokinaasi (cpk) aktiivsuse tõus veres
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
creatine phosphokinase (cpk) 2.5 x uln
kreatiinfosfokinaas (cpk) 2,5 x nÜp
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
cpk levels have not been routinely measured in other populations.
teistes populatsioonides ei määratud rutiinselt cpk taset.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
cpk elevations of any grade were observed in 26% of patients.
kreatiniinfosfokinaasi (cpk) taseme suurenemine ja rabdomüolüüs: mis tahes astme cpk taseme tõusu täheldati 26% patsientidest.
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
patients at higher risk of developing myopathy should have more frequent cpk measurements.
patsientidel, kellel on suurem risk müopaatia tekkeks, tuleb sagedamini mõõta kfk taset.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
cotellic dosing does not need to be modified or interrupted to manage asymptomatic cpk elevations.
asümptomaatilise kfk aktiivsuse suurenemise korral ei ole vaja cotellic’ annust muuta ega ravi katkestada.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
cpk increases in association with rhabdomyolysis were reported in less than 1% of patients.
rabdomüolüüsiga seotud cpk taseme tõusu kirjeldati vähem kui 1% patsientidest.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
one event of rhabdomyolysis was observed in each treatment arm of the study with concurrent increases in blood cpk.
uuringu mõlemas ravirühmas täheldati ühte rabdomüolüüsi juhtu, millega kaasnes vere kfk aktiivsuse tõus.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
2 in some cases of myopathy involving raised cpk and muscle symptoms, the patients also presented with elevated transaminases.
2 mõnedel müopaatia juhtudel, mille korral esinesid suurenenud cpk sisaldus ja lihassümptomid, kaasnes patsientidel ka suurenenud transaminaaside sisaldus.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
investigations in some cases of myopathy involving raised cpk and muscle symptoms, the patients also presented with elevated transaminases.
19 uuringud mõningate tõusnud kfk ja lihassümptomitega müopaatia juhtude puhul esinesid patsientidel ka tõusnud transaminaasid.
마지막 업데이트: 2012-04-11
사용 빈도: 4
품질:
adverse reactions of increased creatine phosphokinase (cpk) were observed with rotigotine in clinical studies conducted in japan.
kreatiniinfosfokinaasi (cpk) tõusu täheldati kõrvaltoimena rotigotiini kliinilistes uuringutes jaapanis.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
increased cpk, myalgia, myositis and rarely, rhabdomyolysis have been reported with the use of protease inhibitors, particularly in combination with nrtis.
proteaasi inhibiitorite kasutamisel on kirjeldatud kreatiinfosfokinaasi (cpk) aktiivsuse suurenemist, müalgiat, müosiiti ja harva rabdomüolüüsi, eriti kui neid kombineeritakse nrti dega.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
increased cpk, myalgia, myositis and, rarely, rhabdomyolysis, have been reported with protease inhibitors, particularly in combination with nucleoside reverse transcriptase inhibitors.
samuti on proteaasi inhibiitoritega täheldatud kreatiniinfosfokinaasi taseme tõusu, lihasvalu, lihastepõletikku ning harva ka rabdomüolüüsi, eriti kasutamisel koos nukleosiidsete pöördtranskriptaasi inhibiitoritega.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질: